Poliovirus biology and pathogenesis

Current Topics in Microbiology and Immunology

Volumn 206, Issue , 1996, Pages 305-325

  Racaniello, V R ^a   Ren, R ^b  

^a College of Physicians and Surgeons ^*  (United States)

^b BRANDEIS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTOPATHOLOGY; HUMAN; MONKEY; MOUSE; NONHUMAN; POLIOMYELITIS; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; REVIEW; TRANSGENIC MOUSE; VIREMIA; VIRULENCE; VIRUS REPLICATION;

MUS MUSCULUS; POLIOVIRUS;

EID: 0030064434     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-85208-4_15     Document Type: Review

References (103)

1. Ahearn J, Hayward S, Hickey J, Fearon D (1988) Epstein-Barr virus (EBV) infection of murine L cells expressing recombinant human EBV/C3d receptor Proc Natl Acad Sci USA 85: 9307-9311
2. Armstrong C (1939) Successful transfer of the Lansing strain of poliomyelitis virus from the cotton rat to the white mouse. Public Health Rep 54: 2302-2305
3. Assaad F, Cockburn WC (1982) The relation between acute persisting spinal paralysis and poliomyelitis vaccine-results of a ten-year enquiry. Bull World Health Organ 60: 231-242
4. Bass DM, Trier JS, Dambrauskas R, Wolf JL (1988) Reovirus type 1 infection of small intestinal epithelium in suckling mice and its effects on M cells. Lab Invest 58: 226-235
5. Blinzinger K, Anzil AP (1974) Neural route of infection in viral disease of the central nervous system. Lancet II: 1374-1375
6. Blinzinger K, Simon J, Magrath D, Boulger L (1969) Poliovirus crystals within the endoplasmic reticulum of endothelial and mononuclear cells in the monkey spinal cord. Science 163: 1336-1337
7. Bodian D (1954a) Viremia in experimental poliomyelitis. 1. General aspects of infection after intramuscular inoculation with strains of high and of low invasiveness Am J Hyg 60: 339-357
8. Bodian D (1954b) Viremia in experimental poliomyelitis. 2 Viremia and the mechanism of the "provoking" effect of injections or trauma. Am J Hyg 60: 359-370
9. Bodian D (1955) Emerging concept of poliomyelitis infection Science 12: 105-108
10. Bodian D (1959) Poliomyelitis: pathogenesis and histopathology. In: Rivers TM, Horsfall FL (eds) Viral and rickettsial infections of man. Lippincott, Philadelphia, pp 479-498
11. Bodian D, Horstmann DH (1965) Polioviruses. In Horsfall FL, Tamm I (eds) Viral and rickettsial infections of man. Lippincott, Philadelphia, pp 430-473
12. Bouchard M, Racaniello VR (1995) Determinants of attenuation and temperature sensitivity in the type 1 poliovirus vaccine strain. J Virol 69: 4972-4978
13. Brown RH, Johnson D, Ogonowski M, Weiner HL (1987) Type 1 human poliovirus binds to human synaptosomes Ann Neurol 21: 64-70
14. Cann AJ, Stanway G, Hughes PJ, Minor PD, Evans DMA, Schild GC, Almond JW (1984) Reversion to neurovirulence of the live-attenuated Sabin type 3 oral poliovirus vaccine. Nucleic Acids Res 12: 7787-7792
15. Christodoulou C, Colbere-Garapin F, Macadam A, Taffs LF, Marsden S, Minor P, Horaud F (1990) Mapping of mutations associated with neurovirulence in monkeys infected with Sabin 1 poliovirus revertants selected at high temperature J Virol 64 4922-4929
16. Colston E, Racaniello VR (1995) Poliovirus variants selected on mutant receptor-expressing cells identify capsid residues that expand receptor recognition J Virol 69: 4823-4829
17. Couderc T, Barzu T, Horaud F, Crainic R (1990) Poliovirus permissivity and specific receptor expression on human endothelial cells Virology 174 95-102
18. Couderc T, Hogle J, Le Blay H, Horaud F, Blondel B (1993) Molecular characterization of mouse-virulent poliovirus type 1 Mahoney mutants: Involvement of residues of polypeptides VP1 and VP2 located on the inner surface of the capsid protein shell. J Virol 67: 3808-3817
19. Couderc T, Guédo N, Calvez V, Pelletier I, Hogle J, Colbère-Garapin F, Blondel B (1994) Substitutions in the capsids of poliovirus mutants selected in human neuroblastoma cells confer on the Mahoney type 1 strain a neurovirulent phenotype in mice. J Virol 68 8386-8391
20. Enders JF, Weller TH, Robbins FC (1949) Cultivation of the Lansing strain of poliomyelitis virus in cultures of various human embryonic tissues. Science 109 85-87
21. Evans DMA, Dunn G, Minor PD, Schild GC, Cann AJ, Stanway G, Almond JW, Currey K, Maizel JV (1985) Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 poliovaccine genome. Nature 314: 548-550
22. Faber HK (1956) The evolution of poliomyelitic infection Pediatrics 17: 278-286
23. Filman DJ, Syed R, Chow M, Macadam AJ, Minor PD, Hogle JM (1989) Structural factors that control conformational transitions and serotype specificity in type 3 poliovirus. EMBO J 8: 1567-1579
24. Flamand A, Gagner J-P, Morrison LA, Fields BN (1991) Penetration of the nervous system of suckling mice by mammalian reoviruses. J Virol 65: 123-131
25. Freistadt MF, Kaplan G, Racaniello VR (1990) Heterogeneous expression of poliovirus receptor-related proteins in human cells and tissues. Mol Cell Biol 10: 5700-5706
26. Gotoh B, Ogasawara T, Toyoda T, Inocencio NM, Hamaguchi M, Nagai Y (1990) An endoprotease homologous to the blood clotting factor X as a determinant of viral tropism in chick embryo. EMBO J 9: 4189-4195
27. Hashimoto I, Hagiwara A, Komatsu T (1984) Ultrastructural studies on the pathogenesis of poliomyelitis in monkeys infected with poliovirus. Acta Neuropathol (Berl) 64 53-60
28. Holland JJ (1961) Receptor affinities as major determinants of enterovirus tissue tropisms in humans. Virology 15 312-326
29. Holland JJ, Hoyer BH (1962) Early stages of enterovirus infection. Cold Spring Harb Symp Quant Biol 27: 101-111
30. Holland JJ, McLaren LC (1959) The mammalian cell-virus relationship II. Adsorption, reception, and eclipse by HeLa cells J Exp Med 109: 487-504
31. Holland JJ, McLaren LC (1961) The location and nature of enterovirus receptors in susceptible cells. J Exp Med 114: 161-171
32. Holland JJ, Mclaren JC, Syverton JT (1959a) The mammalian cell virus relationship III Production of infectious poliovirus by non-primate celts exposed to poliovirus ribonucleic acid Proc Soc Exp Biol Med 100: 843-845
33. Holland JJ, McLaren JC, Syverton JT (1959b) The mammalian cell virus relationship IV. Infection of naturally insusceptible cells with enterovirus ribonucleic acid. J Exp Med 110: 65-80
34. Horie H, Koike S, Kurata T, Sato-Yoshida Y, Ise I, Ota Y, Abe S, Hioki K, Kato H, Taya C, Nomura T, Hashizume S, Yonekawa H, Nomoto A (1994) Transgenic mice carrying the human poliovirus receptor: new animal model for study of poliovirus neurovirulence J Virol 68 681-688
35. Horstmann DM (1952) Poliomyelitis virus in blood of orally infected monkeys and chimpanzees. Proc Soc Exp Biol Med 79 417
36. Horstmann DM, McCollum RW, Mascola AD (1954) Viremia in human poliomyelitis J Exp Med 99: 355-369
37. Hurst EW (1929) The histology of experimental poliomyelitis. J Pathol 32: 457-477
38. Hurst EW (1936) The newer knowledge of virus diseases of the nervous system: a review and an interpretation Brain 59 1-34
39. Jubelt B, Gallez-Hawkins B, Narayan O, Johnson RT (1980a) Pathogenesis of human poliovirus infection in mice. I Clinical and pathological studies J Neuropathol Exp Neurol 39: 138-148
40. Jubelt B, Narayan O, Johnson RT (1980b) Pathogenesis of human poliovirus infection in mice. II. Age-dependency of paralysis. J Neuropathol Exp Neurol 39: 149-158
41. Kanamitsu M, Kasamaki A, Ogawa M, Kasahara S, Imumura M (1967) Immunofluorescent study on the pathogenesis of oral infection of poliovirus in monkey. Jpn J Med Sci Biol 20: 175-191
42. Kaplan AS (1955) Comparison of susceptible and resistant cells to infection with poliomyelitis virus Ann NY Acad Sci 61: 830-839
43. Kaplan G, Freistadt MS, Racaniello VR (1990) Neutralization of poliovirus by cell receptors expressed in insect cells J Virol 64: 4697-4702
44. Kawamura N, Kohara M, Abe S, Komatsu T, Tago K, Arita M, Nomoto A (1989) Determinants in the 5′ noncoding region of poliovirus Sabin 1 RNA that influence the attenuation phenotype. J Virol 63: 1302-1309
45. Koike S, Horie H, Dise I, Okitsu H, Yoshida M, Iizuka N, Takeuthi K, Takegami T, Nomoto A (1990) The poliovirus receptor protein is produced both as membrane-bound and secreted forms. EMBO J 9: 3217-3224
46. Koike S, Taya C, Kurata T, Abe S, Ise I, Yonekawa H, Nomoto A (1991) Transgenic mice susceptible to poliovirus Proc Natl Acad Sci USA 88: 951-955
47. Koike S, Horie H, Sato Y, Ise I, Taya C, Nomura T, Yoshioka I, Yonekawa H, Nomoto A (1993) Poliovirus-sensitive transgenic mice as a new animal model. Dev Biol Stand 78: 101-107
48. Kunin CM, Jordan WS (1961) In vitro adsorption of poliovirus by noncultured tissues Effect of species, age and malignancy Am J Hyg 73: 245-257
49. La Monica N, Meriam C, Racaniello VR (1986) Mapping of sequences required for mouse neurovirulence of poliovirus type 2 Lansing J Virol 57: 515-525
50. La Monica N, Almond JW, Racaniello VR (1987) A mouse model for poliovirus neurovirulence identifies mutations that attenuate the virus for humans. J Virol 61: 2917-2920
51. Landsteiner K, Popper E (1908) Mikroscopische präparate von einem menschlichen und zwei affentuckermarker Wien Klin Wochenschr 21: 1930
52. Levine B, Hardwick JM, Trapp BD, Crawford TO, Bollinger RC, Griffin DE (1991) Antibody-mediated clearance of alphavirus infection from neurons. Science 254: 856-859
53. Li CP, Schaeffer M (1953) Adaptation of type 1 poliomyelitis virus to mice Proc Soc Exp Biol Med 82: 477-481
54. pro. J Virol 68: 7507-7515
55. Macadam AJ, Arnold C, Howlett J, John A, Marsden S, Taffs F, Reeve P, Hamada N, Wareham K, Almond J, Cammack N, Minor PD (1989) Reversion of the attenuated and temperature-sensitive phenotypes of the Sabin type 3 strain of poliovirus in vaccinees. Virology 172: 408-414
56. Macadam AJ, Ferguson G, Arnold C, Minor PD (1991a) An assembly defect as a result of an attenuating mutation in the capsid proteins of poliovirus type 3 vaccine strain J Virol 65: 5225-5231
57. Macadam AJ, Pollard SJ, Ferguson G, Dunn G, Skuce R, Almond JW, Minor PD (1991b) The 5′ noncoding region of the type 2 poliovirus vaccine strain contains determinants of attenuation and temperature sensitivity Virology 181: 451-458
58. Macadam AJ, Pollard SR, Ferguson G, Skuce R, Wood D, Almond JW, Minor PD (1993) Genetic basis of attenuation of the Sabin type 2 vaccine strain of poliovirus in primates. Virology 192 18-26
59. Maddon PJ, Dalgleish AG, McDougal JS, Clapham PR, Weiss RA, Axel R (1986) The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain Cell 47 333-348
60. Martin A, Wychowski C, Couderc T, Crainic R, Hogle J, Girard M (1988) Engineering a poliovirus type 2 antigenic site on a type 1 capsid results in a chimaeric virus which is neurovirulent for mice. EMBO J 7 2839-2847
61. Melnick JL (1985) Enteroviruses: polioviruses, coxsackieviruses, echoviruses and newer enteroviruses In: Fields BN, Knipe DM, Chanock RM, Melnick JL, Roizman B, Shope RE, (eds) "Virology". Raven, New York, pp 705-738
62. Melnick JL (1990) Enteroviruses: polioviruses, coxsackieviruses, echoviruses and newer enteroviruses. In: Fields BN, Knipe DM, Chanock, Hirsch MS, Melnick JL, Monath TP, Roizman B (eds) "Virology" Raven, New York, pp 549-605
63. Mendelsohn C, Wimmer E, Racaniello VR (1989) Cellular receptor for poliovirus: molecular cloning, nucleotide sequence and expression of a new member of the immunoglobulin superfamily. Cell 56: 855-865
64. Minor PD, Dunn G (1988) The effect of sequences in the 5′-noncoding region on the replication of polioviruses in the human gut J Gen Virol 69 1091-1096
65. Minor PD, Dunn G, Evans DMA, Magreth DI, John A, Howlett J, Phillips A, Westrop G, Wareham K, Almond JW, Hogle JM (1989) The temperature-sensitivity of the Sabin type 3 vaccine strain of poliovirus Molecular and structural effects of a mutation in the capsid protein VP3 J Gen Virol 70: 1117-1123
66. Minor PD, Macadam AJ, Stone DM, Almond JW (1993) Genetic basis of attenuation of the Sabin oral poliovirus vaccines Biologicals 21: 357-364
67. Morrison LA, Sidman RL, Fields BN (1991) Direct spread of reovirus from the intestinal lumen to the central nervous system through vagal autonomic nerve fibers Proc Natl Acad Sci USA 88: 3852-3856
68. Moss EG, Racaniello VR (1991) Host range determinants located on the interior of the poliovirus capsid. EMBO J 5: 1067-1074
69. Murray MG, Bradley J, Yang XF, Wimmer E, Moss EG, Racaniello VR (1988) Poliovirus host range is determined a short amino acid sequence in neutralization antigenic site I Science 241: 213-215
70. Nathanson N, Bodian D (1961) Experimental poliomyelitis following intramuscular virus infection. 1 The effect of neural block on a neurotropic and a pantropic strain. Bull Johns Hopkins Hosp 108 308-319
71. Nathanson N, Langmuir A (1963) The Cutter incident poliomyelitis following formaldehyde-inactivated poliovirus vaccination in the United States during the spring of 1955. III. Comparison of the clinical character of vaccinated and contact cases occurring after use of high rate lots of Cutter vaccine Am J Hyg 78: 61-81
72. Nkowane B, Wassilak S, Orenstein W, Bart K, Schonberger L, Hinman A, Kew O (1987) Vaccine-associated paralytic poliomyelitis United States: 1973 through 1984 JAMA 257: 1335-1340
73. Omata T, Kohara M, Kuge S, Komatsu T, Abe S, Semler BL, Kameda A, Itoh H, Arita M, Wimmer E, Nomoto A (1986) Genetic analysis of the attenuation phenotype of poliovirus type 1. J Virol 58: 348-358
74. Palmiter RD (1986) Germ-line transformation of mice. Annu Rev Genet 20: 456-499
75. Pollard SR, Dunn G, Cammack N, Minor PD, Almond JW (1989) Nucleotide sequence of a neurovirulent variant of the type 2 oral poliovirus vaccine. J Virol 63: 4949-4951
76. Racaniello VR (1995) Early events in infection: receptor binding and cell entry In: Rotbart HA (ed) "Human enterovirus infections". American Society for Microbiology, Washington DC, pp 73-93
77. Racaniello VR, Baltimore D (1981) Cloned poliovirus complementary DNA is infectious in mammalian cells Science 214: 916-919
78. Ren R (1992) Development and characterization of a transgenic mouse model for poliomyelitis Columbia University
79. Ren R, Racaniello V (1992a) Human poliovirus receptor gene expression and poliovirus tissue tropism in transgenic mice J Virol 66: 296-304
80. Ren R, Racaniello VR (1992b) Poliovirus spreads from muscle to the central nervous system by neural pathways J Infect Dis 166: 635-654
81. Ren R, Costantini FC, Gorgacz EJ, Lee JJ, Racaniello VR (1990) Transgenic mice expressing a human poliovirus receptor a new model for poliomyelitis Cell 63: 353-362
82. Ren R, Moss EG, Racaniello VR (1991) Identification of two determinants that attenuate vaccine-related type 2 poliovirus. J Virol 65: 1377-1382
83. Sabin AB (1956) Pathogenesis of poliomyelitis: reappraisal in light of new data. Science 123 1151-1157
84. Sabin AB (1957) Properties of attenuated polioviruses and their behavior in human beings. In: Rivers TM (ed) "Cellular biology, nucleic acids and viruses". New York Academy of Science, New York, pp 113-133
85. Sabin AB, Boulger LR (1973) History of Sabin attenuated poliovirus oral live vaccine strains. J Biol Stand 1: 115-118
86. Sabin AB, Ward R (1941) The natural history of human poliomyelitis. I. Distribution of virus in nervous and non-nervous tissues. J Exp Med 73: 771-793
87. Sabin AB, Hennessen WA, Winsser J (1954) Studies on variants of poliomyelitis virus: I Experimental segregation and properties of avirulent variants of three immunologic types. J Exp med 9 551-576
88. Sicinski P, Rowinski J, Warchol JB, Jarzabek Z, Gut W, Szczygiel B, Bielecki K, Koch G (1990) Poliovirus type 1 enters the human host through intestinal M cells. Gastroenterology 98: 56-58
89. Svitkin YV, Cammack N, Minor PD, Almond JW (1990) Translation deficiency of the Sabin type 3 poliovirus genome: Association with an attenuating mutation C472-U Virology 175: 103-109
90. Tardy-Panit M, Blondel B, Martin A, Tekaia F, Horaud F, Delpeyroux F (1993) A mutation in the RNA polymerase of poliovirus type 1 contributes to attenuation in mice J Virol 67: 4630-4638
91. Tatem JM, Weeks-Levy C, Georgiu A, DiMichele SJ, Gorgacz EJ, Racaniello VR, Cano FR (1992) A mutation present in the amino terminus of Sabin 3 poliovirus VP1 protein is attenuating. J Virol 66: 3194-3197
92. Theiler M (1941) Studies on poliomyelitis. Medicine 20 443-462
93. Tyler KL, McPhee DA, Fields BN (1986) Distinct pathways of viral spread in the host determined by reovirus S1 gene segment Science 233: 770-774
94. Tyler KL, Virgin IVth HW, Bassel-Duby R, Fields BN (1989) Antibody inhibits defined stages in the pathogenesis of reovirus serotype 3 infection of the central nervous system. J Exp Med 170 887-900
95. Ward NA, Milstein JB, Hull HF, Hull BP, Kim-Farley RJ (1993) The WHO-EPI initiative for the global eradication of poliomyelitis. Biologicals 21: 327-333
96. Webster RG, Rott R (1987) influenza virus pathogenicity: the pivotal role of hemagglutinin. Cell 50 665-666
97. Wenner HA, Kamitsuka P (1956) Further observations on the widespread distribution of poliomyelitis virus in body tissues following intramuscular inoculation of cynomolgous monkeys. Virology 2: 83-95
98. Wenner HA, Kamitsuka P (1957) Primary sites of virus multiplication following intramuscular inoculation of poliomyelitis virus in cynomolgous monkeys. Virology 3: 429-443
99. Wenner HA, Rabe EF (1953) The recovery of virus from regional lymph nodes of fatal human cases of poliomyelitis. Am J Med Sci 222: 292-299
100. Westrop GD, Evans DMA, Minor PD, Magrath D, Schild GC, Almond JW (1987) Investigation of the molecular basis of attenuation in the Sabin type 3 vaccine using novel recombinant polioviruses constructed from infectious cDNA In The molecular biology of the positive strand RNA viruses Rowlands DJ, Mayo MA, Mahy BWJ (eds) Liss, New York, pp 53-60
101. Westrop GD, Wareham KA, Evans DMA, Dunn G, Minor PD, Magrath DI, Taffs F, Marsden S, Skinner MA, Schild GC, Almond JW (1989) Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine. J. Virol 63: 1338-1344
102. Wimmer E, Hellen C, Cao X (1993) Genetics of poliovirus. Annu Rev Genet 27: 353-436
103. Wolf JC, Rubin DH, Finberg R, Kauffman RS, Sharpe AH, Trier JS, Fields BN (1981) Intestinal M Cells: a pathway for entry of reovirus into the host. Science 2: 471-472